Articles (46)
Articles
06/25/2026
With $15M discovery deal, Boehringer becomes latest Big Pharma to buy into Immunai’s AI platform
Articles
06/25/2026
Israeli-founded AI biotech Immunai launches drug-discovery collaboration
Articles
06/25/2026
Immunai signs up to $15 million research pact with Boehringer Ingelheim
Articles
05/21/2026
Immunai’s digital ‘plumbing’ keeps AstraZeneca coming back
Articles
01/19/2026
Immunai and Bristol Myers Squibb sign AI partnership
Articles
01/15/2026
Immunai, BMS Join Forces to Advance Clinical Development
Articles
01/15/2026
Immunai and Bristol Myers Squibb turn to AI to decode immune responses in clinical trials
Articles
10/16/2025